📊 Using data from 14 European countries, the authors - Gary Macfarlane, Gareth Jones, Ross MacDonald, Ovidiu Rotariu & #EuroSpA collaborators studied how lifestyle factors affect biologics outcomes in axial spondyloarthritis.
@aberdeenepi.bsky.social @garethjones1.bsky.social

The relationship between lifestyle factors and outcome of treatment with TNFα inhibitors in axial spondyloarthritis – results from 14 European countries - BMC Rheumatology Objectives To quantify the influence of lifestyle factors on tumour necrosis factor inhibitor (TNFi) treatment response, in axial spondyloarthritis (axSpA). Methods Data on biologics-naïve adults with...

📰 New in BMC Rheumatology:

Lifestyle factors like smoking, obesity & alcohol impact TNFα inhibitor outcomes in axial SpA (14-country study). Supports integrated care in rheumatology.

Read article👉 shorturl.at/cmBY6

#Rheumatology #AxialSpA #TNFalpha #LifestyleMedicine #BMC #EuroSpA #Publication

👋Meet Dr Ross MacDonald, Research Fellow @uniofaberdeen.bsky.social👨‍🔬

Ross completed his PhD in #Epidemiology, using missing data methods to study how lifestyle factors 🚬🍺 affect biologic treatment success in #AxialSpondyloarthritis & #PsoriaticArthritis using #EuroSpA data 🌍

🔗 tinyurl.com/yrztpnwa